Found: 3
Select item for more details and to access through your institution.
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 430, doi. 10.1007/s10637-021-01195-2
- By:
- Publication type:
- Article
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8695, doi. 10.2147/CMAR.S339891
- By:
- Publication type:
- Article
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1005, doi. 10.1111/1759-7714.13357
- By:
- Publication type:
- Article